Skip to main content
. 2014 May 2;4(4):329–338. doi: 10.5681/apb.2014.048

Table 2. Remaining actives after 5 days of screening (n=3).

Formulations Concentration (n=3)(?) mean SD RSD Remaining a (%)
F1 (B12) 0.070 0.071 0.068 0.070 0.001 1.612 104.78
F2 (B1) 0.111 0.102 0.113 0.109 0.006 5.166 97.63
F3 (B6) 0.248 0.237 0.248 0.244 0.006 2.573 91.04
F4 (B12+B1) 0.053 0.055 0.057 0.055 0.002 3.688 78.94
F5 (B12+B6) 0.065 0.067 0.063 0.065 0.002 2.504 97.47
F6 (B12+B1+B6) 0.027 0.024 0.022 0.025 0.002 8.827 40.90
F7 0.014 0.016 0.016 0.015 0.001 6.884 25.55
F8 0.027 0.021 0.020 0.022 0.004 15.752 31.71
F10 0.015 0.014 0.014 0.014 0.001 5.219 24.77
F11 0.010 0.009 0.008 0.009 0.001 12.916 15.97
F12A 0.011 0.012 0.028 0.017 0.010 56.595 29.32
F12B 0.005 0.004 0.005 0.004 0.001 16.973 7.42
F13A 0.030 0.030 0.032 0.031 0.001 3.103 50.07
F13B 0.001 0.001 0.001 0.001 0.000 0.000 1.89
F14 A1 0.074 0.078 0.072 0.075 0.003 3.962 67.69
F14 A2 0.035 0.036 0.036 0.036 0.001 2.267 52.57
F14 B1 0.026 0.027 0.029 0.027 0.001 4.783 39.93
F14 B2 0.024 0.025 0.027 0.025 0.002 6.208 32.75
F15 0.000 0.000 0.000 0.000 0.000 0.000 0.00

a indicates remaining B12 for all formulations except F2 and F3 for which represents their active ingredients remaining percentage